IP Verse

Methods For Non-Transgenic Genome Editing In Plants

EP3008186

CELLECTIS
Application Number
EP14732023A
Filing Date
Jun 13, 2014
Status
Granted And Under Opposition
Oct 26, 2018
Grant Date
Nov 28, 2018
External Links
Slate, Register

Biblio Summary

The patent EP3008186B1 was granted on Nov 28, 2018 by Cellectis The patent is currently Granted And Under Opposition.

Oppositions Filed by other Companies on the Patent

The table below shows 4 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

KROHER STROBEL RECHTS- UND PATENTANWALTE PARTMBBAug 28, 2019 N.A.
ADEXE S.R.L.Aug 27, 2019 N.A.
N.V. NEDERLANDSCH OCTROOIBUREAUAug 26, 2019ADMISSIBLE
BAYER CROPSCIENCE AG/BAYER INTELLECTUAL PROPERTY GMBHAug 13, 2019ADMISSIBLE

More Opposed Patents of Cellectis

The table below shows the patents of Cellectis that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2997141Cd19 Specific Chimeric Antigen Receptor And Uses ThereofOct 12, 20221
EP3116902Method For Generating T-Cells Compatible For Allogenic TransplantationJan 1, 20204
EP3189073Trophoblast Glycoprotein (5T4, Tpbg) Specific Chimeric Antigen Receptors For Cancer ImmunotherapyDec 25, 20191

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents